NEON Q1 2026 Earnings EPS Misses Estimates Amid Revenue Disclosure Gap Ginkgo Bioworks DNA Q1 2026 Earnings EPS Misses Estimates Stock Gains Despite Headwinds Processa Pharmaceuticals PCSA Q4 2025 Earnings EPS Misses Estimates by a Wide Margin as PreRevenue Biotech Advances Pipeline LGL Q1 2026 Earnings Loss Per Share Disappoints Amid Missing Revenue Data ZNB Q4 2011 Earnings Massive EPS Beat of 523 Powered by Exceptional Quarter XYL Q1 2026 Earnings EPS Beat Drives Modest Stock Uptick